These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 1697743)
1. Liver, kidney, and thoracic organ transplantation under FK 506. Todo S; Fung JJ; Starzl TE; Tzakis A; Demetris AJ; Kormos R; Jain A; Alessiani M; Takaya S; Shapiro R Ann Surg; 1990 Sep; 212(3):295-305; discussion 306-7. PubMed ID: 1697743 [TBL] [Abstract][Full Text] [Related]
2. The question of FK 506 nephrotoxicity after liver transplantation. McCauley J; Takaya S; Fung J; Tzakis A; Abu-Elmagd K; Jain A; Todo S; Starzl TE Transplant Proc; 1991 Feb; 23(1 Pt 2):1444-7. PubMed ID: 1703344 [TBL] [Abstract][Full Text] [Related]
3. FK 506 for liver, kidney, and pancreas transplantation. Starzl TE; Todo S; Fung J; Demetris AJ; Venkataramman R; Jain A Lancet; 1989 Oct; 2(8670):1000-4. PubMed ID: 2478846 [TBL] [Abstract][Full Text] [Related]
4. Kidney transplantation under FK 506. Starzl TE; Fung J; Jordan M; Shapiro R; Tzakis A; McCauley J; Johnston J; Iwaki Y; Jain A; Alessiani M JAMA; 1990 Jul; 264(1):63-7. PubMed ID: 1693970 [TBL] [Abstract][Full Text] [Related]
5. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation. Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103 [TBL] [Abstract][Full Text] [Related]
6. Patient and graft survival in the European Multicentre Liver Study--FK 506 vs cyclosporin A. McMaster P Transpl Int; 1994; 7 Suppl 1():S32-6. PubMed ID: 11271239 [TBL] [Abstract][Full Text] [Related]
7. Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression. Todo S; Fung JJ; Starzl TE; Tzakis A; Doyle H; Abu-Elmagd K; Jain A; Selby R; Bronsther O; Marsh W Ann Surg; 1994 Sep; 220(3):297-308; discussion 308-9. PubMed ID: 7522431 [TBL] [Abstract][Full Text] [Related]
8. Four-year follow-up of a prospective randomized trial of mycophenolate mofetil with cyclosporine microemulsion or tacrolimus following liver transplantation. Fisher RA; Stone JJ; Wolfe LG; Rodgers CM; Anderson ML; Sterling RK; Shiffman ML; Luketic VA; Contos MJ; Mills AS; Ferreira-Gonzalez A; Posner MP Clin Transplant; 2004 Aug; 18(4):463-72. PubMed ID: 15233827 [TBL] [Abstract][Full Text] [Related]
9. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial. Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635 [TBL] [Abstract][Full Text] [Related]
10. Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Fung JJ; Todo S; Jain A; McCauley J; Alessiani M; Scotti C; Starzl TE Transplant Proc; 1990 Feb; 22(1):6-12. PubMed ID: 1689901 [No Abstract] [Full Text] [Related]
11. What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients. Jain A; Reyes J; Kashyap R; Rohal S; Abu-Elmagd K; Starzl T; Fung J Ann Surg; 1999 Sep; 230(3):441-8; discussion 448-9. PubMed ID: 10493490 [TBL] [Abstract][Full Text] [Related]
12. Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation. Plosker GL; Foster RH Drugs; 2000 Feb; 59(2):323-89. PubMed ID: 10730553 [TBL] [Abstract][Full Text] [Related]
13. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group. Gruessner RW Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719 [TBL] [Abstract][Full Text] [Related]
14. Clinical use of FK 506 in liver transplantation. Klintmalm GB Transplant Proc; 1996 Apr; 28(2):974-6. PubMed ID: 8623484 [TBL] [Abstract][Full Text] [Related]
15. A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients. Shenoy S; Hardinger KL; Crippin J; Korenblat K; Lisker-Melman M; Lowell JA; Chapman W Liver Transpl; 2008 Feb; 14(2):173-80. PubMed ID: 18236391 [TBL] [Abstract][Full Text] [Related]
16. A decade (1982 to 1992) of pediatric cardiac transplantation and the impact of FK 506 immunosuppression. Armitage JM; Fricker FJ; del Nido P; Starzl TE; Hardesty RL; Griffith BP J Thorac Cardiovasc Surg; 1993 Mar; 105(3):464-72; discussion 472-3. PubMed ID: 7680396 [TBL] [Abstract][Full Text] [Related]
17. One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults. Todo S; Fung JJ; Tzakis A; Demetris AJ; Jain A; Alessiani M; Takaya S; Day R; Gordon R; Starzl TE Transplant Proc; 1991 Feb; 23(1 Pt 2):1397-402. PubMed ID: 1703340 [TBL] [Abstract][Full Text] [Related]
18. Liver transplantation for primary biliary cirrhosis: influence of primary immunosuppression on survival. Jacob DA; Neumann UP; Bahra M; Langrehr JM; Neuhaus P Transplant Proc; 2005 May; 37(4):1691-2. PubMed ID: 15919432 [TBL] [Abstract][Full Text] [Related]
19. Use of FK 506 in pediatric patients. Tzakis AG; Fung JJ; Todo S; Reyes J; Green M; Starzl TE Transplant Proc; 1991 Feb; 23(1 Pt 2):924-7. PubMed ID: 1703353 [No Abstract] [Full Text] [Related]
20. Pharmacoepidemiology of tacrolimus in pediatric liver transplantation. Riva N; Schaiquevich P; Cáceres Guido P; Halac E; Dip M; Imventarza O Pediatr Transplant; 2017 Aug; 21(5):. PubMed ID: 28574195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]